郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Preclinical Assessment of Ursolic Acid Loaded into Nanostructured Lipid Carriers in Experimental Visceral Leishmaniasis.

期刊：Pharmaceutics发表年份：2021作者：Jéssica Adriana Jesus; Ilza Maria Oliveira Sousa; Thays Nicolli Fragoso da Silva; Aurea Favero Ferreira; Márcia Dalastra Laurenti; Leila Antonangelo; Caroline Silvério Faria; Paulo Cardoso da Costa; Domingos de Carvalho Ferreira; Luiz Felipe Domingue
阅读更多 →

药效评价[New drugs for small animals in 2020].

期刊：Tierarztliche Praxis. Ausgabe K, Kleintiere/Heimtiere发表年份：2021作者：Ilka Ute Emmerich
阅读更多 →

药效评价Euphornin L promotes lipid clearance by dual regulation of LDLR and PCSK9.

期刊：Experimental and therapeutic medicine发表年份：2021作者：Huihui Li; Jun Li; Xianjing Zhang; Jiaomeng Li; Cong Xi; Wenqiong Wang; Youli Lu; Lijiang Xuan
阅读更多 →

药效评价Correction: Nucleosomal Histone Proteins of L. donovani: A Combination of Recombinant H2A, H2B, H3 and H4 Proteins Were Highly Immunogenic and Offered Optimum Prophylactic Efficacy against Leishmania Challenge in Hamsters.

期刊：PloS one发表年份：2021作者：Rajendra K Baharia; Rati Tandon; Amogh A Sahasrabuddhe; Shyam Sundar; Anuradha Dube
阅读更多 →